Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder.
作者信息
Wang William, Volkow Nora D, Wang QuangQiu, Berger Nathan A, Davis Pamela B, Kaelber David C, Xu Rong
机构信息
Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
出版信息
JAMA Netw Open. 2024 Sep 3;7(9):e2435247. doi: 10.1001/jamanetworkopen.2024.35247.
Abstract
摘要
相似文献
1
Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder.
JAMA Netw Open. 2024 Sep 3;7(9):e2435247. doi: 10.1001/jamanetworkopen.2024.35247.
2
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296.
3
Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
Ann Intern Med. 2025 Jul;178(7):930-939. doi: 10.7326/ANNALS-24-00775. Epub 2025 Jun 17.
4
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study.
Mol Psychiatry. 2024 Aug;29(8):2587-2598. doi: 10.1038/s41380-024-02498-5. Epub 2024 Mar 14.
5
Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study.
Drug Des Devel Ther. 2025 Jul 3;19:5645-5652. doi: 10.2147/DDDT.S531778. eCollection 2025.
6
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.
JAMA Ophthalmol. 2025 Apr 1;143(4):304-314. doi: 10.1001/jamaophthalmol.2024.6555.
7
The Cardiac and Renal Safety of Semaglutide in Patients with Type 2 Diabetes: A Real-World Study Based on FAERS.
Cardiorenal Med. 2025;15(1):413-422. doi: 10.1159/000546238. Epub 2025 May 11.
8
Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity.
JAMA Netw Open. 2025 Jul 1;8(7):e2521016. doi: 10.1001/jamanetworkopen.2025.21016.
9
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.
Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.
10
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US.
Alzheimers Dement. 2024 Dec;20(12):8661-8672. doi: 10.1002/alz.14313. Epub 2024 Oct 24.
引用本文的文献
1
Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling: Making the Case for a Functionally G Protein-Selective GPCR.
Int J Mol Sci. 2025 Jul 26;26(15):7239. doi: 10.3390/ijms26157239.
2
Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes.
JAMA Netw Open. 2025 Aug 1;8(8):e2526327. doi: 10.1001/jamanetworkopen.2025.26327.
3
Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study.
J Alzheimers Dis. 2025 Jun 24:13872877251351329. doi: 10.1177/13872877251351329.
4
Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications.
Biomolecules. 2025 Apr 26;15(5):622. doi: 10.3390/biom15050622.
5
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy.
Prog Cardiovasc Dis. 2025 Mar-Apr;89:102-112. doi: 10.1016/j.pcad.2024.12.010. Epub 2024 Dec 30.
本文引用的文献
1
Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes : Target Trial Emulation Using Real-World Data.
Ann Intern Med. 2024 Aug;177(8):1016-1027. doi: 10.7326/M23-2718. Epub 2024 Jul 30.
2
Treatment for Opioid Use Disorder: Population Estimates - United States, 2022.
MMWR Morb Mortal Wkly Rep. 2024 Jun 27;73(25):567-574. doi: 10.15585/mmwr.mm7325a1.
3
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population.
Nat Commun. 2024 May 28;15(1):4548. doi: 10.1038/s41467-024-48780-6.
4
Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats.
Brain Res Bull. 2022 Oct 15;189:163-173. doi: 10.1016/j.brainresbull.2022.08.022. Epub 2022 Aug 28.
Zotero 插件